212 related articles for article (PubMed ID: 25236422)
1. Hematologic indices as surrogate markers for monitoring thiopurine therapy in IBD.
Kopylov U; Battat R; Benmassaoud A; Paradis-Surprenant L; Seidman EG
Dig Dis Sci; 2015 Feb; 60(2):478-84. PubMed ID: 25236422
[TBL] [Abstract][Full Text] [Related]
2. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
Yarur AJ; Gondal B; Hirsch A; Christensen B; Cohen RD; Rubin DT
J Clin Gastroenterol; 2018 Jul; 52(6):537-544. PubMed ID: 28723860
[TBL] [Abstract][Full Text] [Related]
3. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
Heerasing NM; Ng JF; Dowling D
Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
[TBL] [Abstract][Full Text] [Related]
5. Mean Corpuscular Volume to White Blood Cell Ratio for Thiopurine Monitoring in Pediatric Inflammatory Bowel Disease.
Kandavel P; Eder SJ; Newman NE; Waljee AK; Whitfield EP; Adler J
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):88-94. PubMed ID: 30747813
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn's disease.
Essmann J; Keil C; Unruh O; Otte A; Manns MP; Bachmann O
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):99-108. PubMed ID: 30212402
[TBL] [Abstract][Full Text] [Related]
7. Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
Jagt JZ; Pothof CD; Buiter HJC; van Limbergen JE; van Wijk MP; Benninga MA; de Boer NKH; de Meij TGJ
Dig Dis Sci; 2022 Jan; 67(1):241-251. PubMed ID: 33532972
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
Stocco G; Cuzzoni E; De Iudicibus S; Favretto D; Malusà N; Martelossi S; Pozzi E; Lionetti P; Ventura A; Decorti G
World J Gastroenterol; 2015 Mar; 21(12):3571-8. PubMed ID: 25834322
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1407-13. PubMed ID: 15618853
[TBL] [Abstract][Full Text] [Related]
12. Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease.
Poon SS; Asher R; Jackson R; Kneebone A; Collins P; Probert C; Dibb M; Subramanian S
J Crohns Colitis; 2015 Aug; 9(8):640-6. PubMed ID: 25968584
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study.
Meijer B; Wilhelm AJ; Mulder CJJ; Bouma G; van Bodegraven AA; de Boer NKH
Ther Drug Monit; 2017 Aug; 39(4):399-405. PubMed ID: 28489727
[TBL] [Abstract][Full Text] [Related]
15. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674
[TBL] [Abstract][Full Text] [Related]
16. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
[TBL] [Abstract][Full Text] [Related]
17. RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine.
D'Halluin PN; Tribut O; Branger B; Lebreton C; Bretagne JF; Bentue-Ferrer D; Heresbach D
Gastroenterol Clin Biol; 2005 Dec; 29(12):1264-9. PubMed ID: 16518285
[TBL] [Abstract][Full Text] [Related]
18. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Angelberger S; Schaeffeler E; Teml A; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Schwab M; Reinisch W
Inflamm Bowel Dis; 2013 Mar; 19(3):590-8. PubMed ID: 23388543
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
